Navigation Links
Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
Date:3/19/2013

healthcare spending.
•In the biotechnology industry, companies within low revenue range and relatively new products have witnessed negative margins because of the heavy investment in R&D and SG&A (selling and general expenses).

2. Profitability Analysis
•Companies with a large portfolio of drugs have seen higher profitability in the pharmaceutical industry.
•The long timelines and accumulating expenditures incurred before a drug is commercialized is making the biotechnology industry less profitable in initial years, even resulting in negative margins for companies that are smaller in terms of revenue.

3. Turnover Analysis
•In both the pharmaceutical and biotechnology industries, companies with lower revenue had poor turnover ratios because of the huge investments made in assets and in the development of the product.

4. Cash Reserve Analysis
•In the pharmaceutical industry the smaller companies in terms of revenue are increasing their cash reserve as a percentage of their assets.
•In the biotechnology industry, both small and large companies in terms of revenue are increasing their cash reserve as a percentage of their assets.

5. R&D to Sales Ratio
•Both the pharmaceutical and biotechnology industries did not witness a great variation in the R&D to sales ratio in 2011 compared to the previous year. Though there was a general decline in the overall sales in both the pharmaceutical and biotechnology industries, the R&D expenses were not considerably reduced.

Who Will Benefit?

•Pharmaceutical & biotechnology companies
•Private equity
•Venture capital investors
•Fund managers
•Retail investors
•Sovereign wealth funds
•Hedge funds
•Insurance funds and other members of the investing community

Table Of Contents

1. Executive Summary

'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
2. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
3. Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update
4. Organovo Reports 2012 Financial Results
5. Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance
6. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
7. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
8. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
9. Discovery Labs Reports Fourth Quarter 2012 Financial Results
10. GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2012
11. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated ... subsidiary, Qualcomm Life, Inc., is collaborating ... chronic care management solutions powered by Qualcomm Life,s ... Platform to enable continuous care, informed interventions and ... announced at Qualcomm Life,s annual Connect 2015 ...
(Date:8/31/2015)... PARK, Calif. , Aug. 31, 2015 /PRNewswire/ ... company focused on the emerging field of regenerative ... successfully dosed at Chicago -based ... clinical trial evaluating activity of escalating doses of ... with sensory and motor complete cervical spinal cord ...
(Date:8/31/2015)...  QT Vascular Ltd., together with its subsidiaries ... its subsidiaries, the "Group"), a global company engaged ... therapeutic solutions for the minimally invasive treatment of ... the below-the-knee ("BTK") cohort of patients in the ... on August 15, 2015 at the 5th Annual ...
Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... May 3, 2012  Abbott (NYSE: ABT ), ... plans to establish its first nutrition research and development ... leading contract research organization. The Abbott Nutrition R&D Center ... affordable nutrition products for the country and enable the ...
... 2012  Hill-Rom Holdings, Inc. (NYSE: HRC ) announced ... year 2012 third quarter dividend of $0.125 per share. This ... record as of the close of business on June 15, ... Hill-Rom is a leading worldwide manufacturer and provider of ...
Cached Medicine Technology:Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India 2Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India 3Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India 4
(Date:8/31/2015)... Plains, NJ (PRWEB) , ... August 31, 2015 ... ... practice! Garden State Urology was formed in 2008, the result of a merger ... the principle that by working cooperatively, they could provide more cost-effective and higher ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, ... Doc”!, Born and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don ... and ice hockey and served as team captain in both sports in his senior year. ...
(Date:8/31/2015)... ... 31, 2015 , ... Dr. Stewart Shofner of Shofner Vision Center ... Month. Only a comprehensive eye examination can diagnose amblyopia. According to the National ... children, affecting approximately 2 to 3 out of every 100 children. , Dr. ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... company announced today that it has officially launched a new website and company ... and brand refresh are more closely aligned with the company’s strategic vision for ...
(Date:8/31/2015)... ... August 31, 2015 , ... Three Bakers Gluten Free Bakery launched the ... more relevant and easy-to-find information on their offering of gluten-free breads and pizzas, living ... an important way for us to share information about our gluten free product offerings, ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... banned all imports of poultry from UK to prevent the spread ... said in statement// as soon as the British ministry informed them ... ,This virus is less dangerous to humans than the H5N1 ... worker in UK. Its incidence of late is on the rise ...
... turn camel milk, a healthier option than cow's milk, into the ... method of milking normally yields some 1.5 litres of milk per ... litres produced by cows. //Yagil, however, says he has developed a ... ,Traditionally seen as riding and pack animals, camels are hugely ...
... a high risk of contracting severe injuries, more specifically sideswipe injuries ... which can be cited in the latest edition of Medical Journal ... driver resting his/her hands on the car window, in a relaxed ... to the protruding limb/elbow. ,In an attempt to identify ...
... the levels of a hormone found in the stomach ... activity in overweight and obese people. // ,The ... International Journal of Obesity. ,The research team ... oxyntomodulin to fifteen overweight volunteers from Hammersmith Hospital. They ...
... UK couples go abroad in order to undergo fertility treatment. ... own country is that there is a long waiting list ... //were removed by a law. Hence European fertility clinics are ... and Embryology Authority (HFEA) is warning people about the mad ...
... IVF on the grounds that she was a lesbian, ... ,According to Lambda Legal lawyer Jennifer Pizer ... violates California civil rights law. The suit was announced ... doctors however claimed that being fundamental Christians prevented them ...
Cached Medicine News:Health News:Milking the ship of the desert for 'white gold' 2Health News:Watch Out! Sideswipe Elbow Injuries On The Rise 2Health News:Lesbian Sues Doctors 2
... first time, the Integrated Cytometry Solution ... post-analytical solution coupled with complete LIS ... steps a sample undergoes - and ... one - it delivers a progressive ...
Convective Air Warming Blankets...
MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...
Inquire...
Medicine Products: